Showing items related by title, author, creator and subject.

• Improving informed consent: the medium is not the message 

  Agre, Patricia; Campbell, Frances A.; Goldman, Barbara D.; Boccia, Maria L.; Kass, Nancy; McCullough, Laurence B.; Merz, Jon F.; Miller, Suzanne M.; Mintz, Jim; Rapkin, Bruce; Sugarman, Jeremy; Sorenson, James; Wirshing, Donna (2003-09)
• Conducting Empirical Research on Informed Consent: Challenges and Questions 

  Sachs, Greg A.; Hougham, Gavin W.; Sugarman, Jeremy; Agre, Patricia; Broome, Marion E.; Geller, Gail; Kass, Nancy; Kodish, Eric; Mintz, Jim; Roberts, Laura W.; Sankar, Pamela; Siminoff, Laura A.; Sorenson, James; Weiss, Anita (2003-09)
• Challenges to Effective Research in Acute Trauma Resuscitation: Consent and Endpoints 

  Holcomb, John B; Weiskopf, Richard; Champion, Howard; Gould, Steven A; Sauer, R Michelle; Brasel, Karen; Bochicchio, Grant; Bulger, Eileen; Cotton, Bryan A; Davis, Daniel; Dutton, Richard; Hauser, Carl J; Hess, John R; Hides, George A; Knudson, Paula; MacKenzie, Ellen; McGinnis, Robert L; Michalek, Joel; Moore, Frederick A; Omert, Laurel; Pollock, Brad H; Tortella, Bartholomew; Sugarman, Jeremy; Schreiber, Martin A; Wade, Charles E (2011-02)

  Selection of study endpoints is one of the most important decisions in the design of effective clinical trials. Late mortality (e.g., 28 days) is an unambiguous endpoint, accepted by regulatory agencies, but it is viewed ...